Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK
Search for other papers by Wiebke Arlt in
Google Scholar
PubMed
Search for other papers by the Society for Endocrinology Clinical Committee in
Google Scholar
PubMed
drop Take drug history (glucocorticoids?) Bloods: Sodium, potassium, urea, creatinine Full blood counts TSH, fT 4 (hyperthyroidism can trigger adrenal crisis; acute adrenal insufficiency can increase TSH due to loss of inhibitory control of
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Guangdong Geriatric Institute, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
Search for other papers by Qinglei Yin in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Zhou Jin in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Yulin Zhou in
Google Scholar
PubMed
Reproductive Medicine Center, Guangdong Provincial People’s Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
Search for other papers by Dalong Song in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Chenyang Fu in
Google Scholar
PubMed
Division of Endocrinology, Department of Internal Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Search for other papers by FengJiao Huang in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai National Center for Translational Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Shu Wang in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is an autoimmune disorder characterized by the presence of autoantibodies that bind to and stimulate the thyrotropin receptor, resulting in hyperthyroidism and goiter ( 1 ). It is suggested that the
Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Ling Sun in
Google Scholar
PubMed
Search for other papers by Wenwu Zhu in
Google Scholar
PubMed
Search for other papers by Yuan Ji in
Google Scholar
PubMed
Search for other papers by Ailin Zou in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Lipeng Mao in
Google Scholar
PubMed
Dalian Medical University, Dalian, Liaoning, China
Search for other papers by Boyu Chi in
Google Scholar
PubMed
Search for other papers by Jianguang Jiang in
Google Scholar
PubMed
Search for other papers by Xuejun Zhou in
Google Scholar
PubMed
Search for other papers by Qingjie Wang in
Google Scholar
PubMed
Search for other papers by Fengxiang Zhang in
Google Scholar
PubMed
after AKI onset. Serum TSH level was tested by enhanced chemiluminescence assay ( 21 ). The reference range was 3.1–6.8 pmol/L for FT3, 12–22 pmol/L for free thyroxine (FT4), and 0.27–4.2 µIU/mL for TSH in adults. Hyperthyroidism was diagnosed as
Search for other papers by Paolo G Arduino in
Google Scholar
PubMed
Search for other papers by Dora Karimi in
Google Scholar
PubMed
Search for other papers by Federico Tirone in
Google Scholar
PubMed
Search for other papers by Veronica Sciannameo in
Google Scholar
PubMed
Search for other papers by Fulvio Ricceri in
Google Scholar
PubMed
Search for other papers by Marco Cabras in
Google Scholar
PubMed
Search for other papers by Alessio Gambino in
Google Scholar
PubMed
Search for other papers by Davide Conrotto in
Google Scholar
PubMed
Search for other papers by Stefano Salzano in
Google Scholar
PubMed
Search for other papers by Mario Carbone in
Google Scholar
PubMed
Search for other papers by Roberto Broccoletti in
Google Scholar
PubMed
.6%) Hyperthyroidism 4 (5.6%) 1 (4.6%) Autoimmune hypothyroidism 30 (42.3%) 11 (50%) Not autoimmune hypothyroidism 28 (39.4%) 7 (31.8%) P -value = 0.91 Patients on active treatment for hypothyroidism at baseline No. 51
Search for other papers by Bliss Anderson in
Google Scholar
PubMed
Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
± levothyroxine/oestrogen/testosterone) Usually 6–14 weeks after treatment Thyroid dysfunction 5.2–8% overall (8, 9, 49, 50) More commonly seen in anti-PD-1 or anti-PD-L1 therapies (49, 50) May present with hyperthyroidism symptoms prior to
Search for other papers by Dimitra Argyro Vassiliadi in
Google Scholar
PubMed
Search for other papers by Ioannis Ilias in
Google Scholar
PubMed
Search for other papers by Maria Pratikaki in
Google Scholar
PubMed
Search for other papers by Edison Jahaj in
Google Scholar
PubMed
Search for other papers by Alice G Vassiliou in
Google Scholar
PubMed
Search for other papers by Maria Detsika in
Google Scholar
PubMed
Search for other papers by Kleio Ampelakiotou in
Google Scholar
PubMed
Search for other papers by Marina Koulenti in
Google Scholar
PubMed
Search for other papers by Konstantinos N Manolopoulos in
Google Scholar
PubMed
Search for other papers by Stamatis Tsipilis in
Google Scholar
PubMed
Search for other papers by Evdokia Gavrielatou in
Google Scholar
PubMed
Search for other papers by Aristidis Diamantopoulos in
Google Scholar
PubMed
Search for other papers by Alexandros Zacharis in
Google Scholar
PubMed
Search for other papers by Nicolaos Athanasiou in
Google Scholar
PubMed
Search for other papers by Stylianos Orfanos in
Google Scholar
PubMed
Search for other papers by Anastasia Kotanidou in
Google Scholar
PubMed
Search for other papers by Stylianos Tsagarakis in
Google Scholar
PubMed
Search for other papers by Ioanna Dimopoulou in
Google Scholar
PubMed
subclinical hyperthyroidism were not different to those with normal thyroid function test or those with patterns compatible with NTIS (14.5 ± 12.6 ng/mL vs 13.6 ± 11.9 ng/mL vs 18.3 ± 20.3 ng/mL, respectively, P = NS). Hypothyroidism Of note
Department of Endocrinology, The People’s Hospital of Daxing District, Beijing, China
Search for other papers by Ya-Fen Hu in
Google Scholar
PubMed
Search for other papers by Lin Hua in
Google Scholar
PubMed
Search for other papers by Xiu Tuo in
Google Scholar
PubMed
Search for other papers by Ting-Ting Shi in
Google Scholar
PubMed
Search for other papers by Yi-Lin Yang in
Google Scholar
PubMed
Search for other papers by Yun-Fu Liu in
Google Scholar
PubMed
Search for other papers by Zhong-Yu Yan in
Google Scholar
PubMed
Search for other papers by Zhong Xin in
Google Scholar
PubMed
inflammation of the orbital tissues, which is known as GO ( 1 ). It occurs in patients with hyperthyroidism, hypothyroidism, or normal thyroid function. However, the pathogenesis underlying the disease has not yet been clarified. Several factors, including
Search for other papers by Changjiao Yan in
Google Scholar
PubMed
Search for other papers by Meiling Huang in
Google Scholar
PubMed
Search for other papers by Xin Li in
Google Scholar
PubMed
Search for other papers by Ting Wang in
Google Scholar
PubMed
Search for other papers by Rui Ling in
Google Scholar
PubMed
.4) 4.196 0.041 No 325 (16.6) 1630 (83.4) Concomitant hypertension Yes 18 (7.0) 238 (93.0) 18.300 <0.001 No 315 (17.6) 1477 (82.4) Concomitant benign thyroid diseases Hyperthyroid
Search for other papers by Stavroula Stavrou in
Google Scholar
PubMed
Search for other papers by Michael Gratz in
Google Scholar
PubMed
Search for other papers by Eileen Tremmel in
Google Scholar
PubMed
Search for other papers by Christina Kuhn in
Google Scholar
PubMed
Search for other papers by Simone Hofmann in
Google Scholar
PubMed
Search for other papers by Helene Heidegger in
Google Scholar
PubMed
Search for other papers by Mina Peryanova in
Google Scholar
PubMed
Search for other papers by Kerstin Hermelink in
Google Scholar
PubMed
Search for other papers by Stefan Hutter in
Google Scholar
PubMed
Search for other papers by Bettina Toth in
Google Scholar
PubMed
Search for other papers by Doris Mayr in
Google Scholar
PubMed
Search for other papers by Sven Mahner in
Google Scholar
PubMed
Search for other papers by Udo Jeschke in
Google Scholar
PubMed
Search for other papers by Aurelia Vattai in
Google Scholar
PubMed
Introduction Thyroid disorders such as hypothyroidism and hyperthyroidism are associated with increased miscarriage and stillbirth rates ( 1 ). Untreated hypothyroidism can result in a twofold increase of miscarriages; therefore, the
Department of Pediatric Cardiology, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Xuechao Jiang in
Google Scholar
PubMed
Search for other papers by Yonghui Wang in
Google Scholar
PubMed
Search for other papers by Xiaoying Li in
Google Scholar
PubMed
Search for other papers by Leqi He in
Google Scholar
PubMed
Search for other papers by Qian Yang in
Google Scholar
PubMed
Search for other papers by Wei Wang in
Google Scholar
PubMed
Search for other papers by Jun Liu in
Google Scholar
PubMed
Search for other papers by Bingbing Zha in
Google Scholar
PubMed
Introduction Graves’ disease (GD) is the most common cause of hyperthyroidism and diffuse goiter, affecting 1.0–1.5% of the population ( 1 ). GD is characterized by lymphocytic infiltration and the production of autoantibodies directed against